Print

Purpose

The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pregnant patients with a new diagnosis of fetal growth restriction (estimated fetal weight <10th percentile or abdominal circumference <10th percentile) in the third trimester (gestational age >27w6d)

Exclusion Criteria

  • Multiple gestation - Fetal anomalies - Gestational diabetes or pregestational diabetes.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Fetal Growth Restriction diagnosed > 27w6d gestation Patients with a new diagnosis of fetal growth restriction after 27 weeks 6 days' gestation.
  • Device: USCOM
    Device that measures how much blood is being pumped in and out of the heart.

Recruiting Locations

Mount Sinai Hospital
New York, New York 10029
Contact:
Nicola F Tavella, MPH
2122413888
nicola.tavella@mssm.edu

More Details

Status
Recruiting
Sponsor
Icahn School of Medicine at Mount Sinai

Study Contact

Nicola F Tavella, MPH
212-241-3888
nicola.tavella@mssm.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.